Fierce Pharma

AUGUST 15, 2024

Just as a new strain of mpox spreads across Africa, results from a preliminary analysis of a study that began during the 2022 viral outbreak stands to provide more clarity on the clinical benefit o | Despite missing the trial's primary endpoint of time to lesion resolution, the study suggested that the treatment may be most beneficial for those treated early and those with severe disease.

264

264

MedCity News

AUGUST 15, 2024

The first 10 drugs selected for Medicare price negotiations now have new prices set to take effect in 2026. Industry observers note that most of these drugs are older products facing generic competition soon, so greater industry impact will come as the program expands to more drugs in years to come. The post CMS Touts First Negotiated Drug Prices, But Greater Impact Expected in Future Rounds appeared first on MedCity News.

Competition 122

Competition Biopharma Pharma 122

Fierce Pharma

AUGUST 15, 2024

Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the | Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the patents behind the original lawsuit.

249

249

MedCity News

AUGUST 15, 2024

Retailers aren’t giving up on healthcare — but they are trying to be more strategic in their efforts to disrupt the space. As these companies re-strategize, experts think they need to center their efforts on building trust and fostering long-term patient engagement. The post What Will the Future of Retail Health Look Like? appeared first on MedCity News.

Retail 117

Retail Healthcare Healthcare Patients 117

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Fierce Pharma

AUGUST 15, 2024

So far in August, the FDA has announced two separate drug recalls on its website: one related to particulate concerns and the other thanks to high endotoxin levels. | So far in August, the FDA has announced two separate drug recalls on its website: one related to particulate concerns and the other thanks to high endotoxin levels. While neither recall has resulted in any safety flags or side effect reports so far, the issues stemming from the faulty products could be severe, the drugmakers have w

Side effects 198

Side effects Safety FDA 198

MedCity News

AUGUST 15, 2024

Through a new partnership with Good Measures, some Point32Health members have gained access to nutrition counseling, food tracking and other services. The post Good Measures, Point32Health Launch Food as Medicine Partnership appeared first on MedCity News.

Food 110

Food Medicine 110

MedCity News

AUGUST 15, 2024

Participant payment options should include a variety of stipend and micropayment methods to meet participant preferences. Increasing the diversity of payment methods with both banked and unbanked options enhances flexibility, catering to a diverse and international participant base with varying payout needs. The post Streamlined Participant Payments Unlock Clinical Trial Access for All appeared first on MedCity News.

Biopharma 102

Biopharma Patients Pharma 102

Fierce Pharma

AUGUST 15, 2024

The TROP2 antibody-drug conjugate race has heated up among three Big Pharma companies: Gi | In this week’s episode of “The Top Line,” Fierce executive editor Eric Sagonowsky chats with Angus Liu about his feature story on the three TROP2 front-runners.

Pharma 144

Pharma 144

PharmaVoice

AUGUST 15, 2024

A long-time leader in public health and outreach to people of color, Dr. Reed Tuckson offers the lessons he learned from the COVID pandemic and how pharma can better serve those communities.

Healthcare 96

Healthcare Healthcare Pharma 96

pharmaphorum

AUGUST 15, 2024

FDA clears Incyte's potential blockbuster Niktimvo as a treatment for chronic GvHD, making it a companion to the company's Jakafi for the disorder.

FDA 105

FDA 105

Advertisement

MedCity News

AUGUST 15, 2024

As we send our kids back to school this fall, let’s remember that a healthy smile is about more than looks — it’s about giving our children the best possible start in life, free from the pain and distraction of dental problems, which are likely to occur if left untreated. The post Back to School and Oral Health appeared first on MedCity News.

Physicians 98

Physicians Patients 98

Pharmaceutical Technology

AUGUST 15, 2024

Strong measures must be in place to safeguard confidential patient data when deploying AI to optimise clinical trial translations.

Patients 107

Patients 107

pharmaphorum

AUGUST 15, 2024

AstraZeneca's plan to invest £450m in a vaccines plant in the UK has been thrown into doubt by a bid to slash state aid, reports FT

101

101

Eversana Intouch

AUGUST 15, 2024

In the ever-evolving landscape of healthcare marketing, understanding audience engagement and measuring success is paramount. In a recent PM360 Think Tank article , Iyiola Obayomi, SVP, Managing Director of Analytics, shared his expertise on mastering metrics. Let’s explore key insights from his perspective. Audience-Centric Metrics: Historically, marketers relied on superficial metrics like likes and shares.

Education 59

Education Marketing Medical Prescription 59

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales

pharmaphorum

AUGUST 15, 2024

Large language models (LLMs) find it hard to identify genetic conditions based on patient-written descriptions, say NIH researchers.

Patients 98

Patients 98

PharmaTimes

AUGUST 15, 2024

Children accounted for the majority of mpox cases and deaths in the DRC since June 2023

85

85

pharmaphorum

AUGUST 15, 2024

FDA approves Gilead's Livdelzi for primary biliary cholangitis, setting up a contest with Ipsen's recent launch Iqirvo in the second-line setting

FDA 90

FDA 90

PharmaTech

AUGUST 15, 2024

National Institutes of Health’s National Institute of Allergy and Infectious Diseases collaborated with the University of Sciences, Techniques and Technologies of Bamako, Mali to conduct the trials.

52

52

Advertisement

Distribution

pharmaphorum

AUGUST 15, 2024

A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales.

70

70

PharmExec

AUGUST 15, 2024

How drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.

Marketing 52

Marketing 52

European Pharmaceutical Review

AUGUST 15, 2024

Two trials ( Phase I and Phase II ) of a vaccine given to healthy adults from Mali has demonstrated its potential as a safe and effective way to immunise against malaria, prior to and during pregnancy. In one trial, the PfSPZ vaccine was evaluated in 300 healthy women ages 18 to 38 years. These individuals hoped to become pregnant soon after being vaccinated.

Safety 52

Safety Pharmaceutical 52

PharmExec

AUGUST 15, 2024

The importance of pre-approval information exchange (PIE) with payers and other strategic considerations to help navigate today’s market access challenges and regulatory requirements in bringing promising cell and gene therapies to the market.

Marketing 52

Marketing 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharmaceutical Commerce

AUGUST 15, 2024

In this part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ Senior Director of DSCSA/Serialization Compliance Services, predicts the likelihood of stabilization period postponement.

Pharma 52

Pharma 52

PharmExec

AUGUST 15, 2024

To safeguard patient access to life-saving medications, pharma companies must prioritize building robust resilience strategies that encompass IT systems, inventory management, risk mitigation, and regulatory compliance.

Pharma 52

Pharma Management Medical Patients 52

PharmaVoice

AUGUST 15, 2024

The agency said the first round of pricing talks, which involved drugs like the blood thinners Eliquis and Xarelto, will result in $6 billion in savings for taxpayers.

52

52

PharmaTimes

AUGUST 15, 2024

Combined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK

74

74

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Pharmaceutical Technology

AUGUST 15, 2024

Livdelzi is said to be effective against primary biliary cholangitis (PBC) for patients unresponsive to standard-of-care therapy.

Patients 59

Patients 59

PharmExec

AUGUST 15, 2024

Approval of Livdelzi is based on results from the Phase III RESPONSE study, which demonstrated improved key biochemical markers and reduced pruritus.

FDA 52

FDA 52

Pharmaceutical Technology

AUGUST 15, 2024

Evotec’s CEO Christian Wojczewski had previously announced a strategic reset after shutting down its gene therapy business earlier this year.

Marketing 52

Marketing 52

PharmExec

AUGUST 15, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety